// App-Quantinova.ai

429 : Establishment of the classifier for a response to vascular endothelial growth factor (VEGF)-tyrosine kinase inhibitor (TKI) in metastatic renal cell carcinoma

Researchers

Presenter

  • Heounjeong Go

Principal Investigators

  • Mun Jung Kang

  • Pil-Jong Kim

  • Ja-Min Park

  • Jae-Lyun Lee

  • Ji Young Park

  • Yong Mee Cho

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

  • Solid malignancies

Biomarkers

  • Carbonic anhydrase IX

  • Phosphorylated-AKT

  • Platelet-derived growth factor receptor

  • Programmed cell death 1 ligand 2

  • Programmed death-ligand 1

  • Fibroblast Growth Factor Receptor 2

  • Hypoxia-inducible factor-1

  • Interleukin-8

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved